Clinical Trials
11 trialsNCT03323658 2023-01-10
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01009437 2017-12-05
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00788112 2017-08-07
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
University of California, San Francisco
Phase 1 Completed
NCT02391194 2017-03-22
Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
Avelas Biosciences, Inc.
Phase 1 Completed
NCT00005886 2017-01-13
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
University of Kansas Medical Center
Phase 1 Completed
NCT00637481 2016-12-29
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01372644 2016-12-05
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NYU Langone Health
Phase 1 Completed
NCT00107211 2014-09-17
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00290732 2013-10-31
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00245024 2013-05-03
Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00749437 2012-06-14
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
Rutgers, The State University of New Jersey
Phase 1 Completed